Von Willebrand disease historical perspective

Jump to navigation Jump to search

Von Willebrand disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Von Willebrand disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Von Willebrand disease historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Von Willebrand disease historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Von Willebrand disease historical perspective

on Von Willebrand disease historical perspective

Von Willebrand disease historical perspective in the news

Blogs on Von Willebrand disease historical perspective

Directions to Hospitals Treating Von Willebrand disease

Risk calculators and risk factors for Von Willebrand disease historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

  • In the mid 1950s it was recognized that Von Willebrand's disease was usually accompanied by the following:[3]
    • A decreased level of coagulation factor VIII (FVIII) activity
    • Bleeding phenotype could be corrected by the infusion of normal plasma.
  • In the early 1970s the immunologic distinction between FVIII and von Willebrand factor was made.[3]
  • In the 1980s, cloning of the VWF gene was investigated which has facilitated investigation into the genetic basis of VWD.[3][4][5][6][7]

Historical Perspective

  • In the mid 1950s it was recognized that Von Willebrand's disease was usually accompanied by the following:[3]
    • A decreased level of coagulation factor VIII (FVIII) activity
    • Bleeding phenotype could be corrected by the infusion of normal plasma.
  • In the early 1970s the immunologic distinction between FVIII and von Willebrand factor was made.[3]
  • In the 1980s, cloning of the VWF gene was investigated which has facilitated investigation into the genetic basis of VWD.[3][4][5][6][7]

References

  1. Template:WhoNamedIt
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Lenting PJ, Casari C, Christophe OD, Denis CV (2012). "von Willebrand factor: the old, the new and the unknown". J Thromb Haemost. 10 (12): 2428–37. doi:10.1111/jth.12008. PMID 23020315.
  3. 3.0 3.1 3.2 3.3 3.4 3.5 James PD, Goodeve AC (2011). "von Willebrand disease". Genet Med. 13 (5): 365–76. doi:10.1097/GIM.0b013e3182035931. PMC 3832952. PMID 21289515.
  4. 4.0 4.1 Lynch DC, Zimmerman TS, Collins CJ, Brown M, Morin MJ, Ling EH; et al. (1985). "Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method". Cell. 41 (1): 49–56. PMID 3873280.
  5. 5.0 5.1 Sadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW (1985). "Cloning and characterization of two cDNAs coding for human von Willebrand factor". Proc Natl Acad Sci U S A. 82 (19): 6394–8. PMC 390722. PMID 2864688.
  6. 6.0 6.1 Ginsburg D, Handin RI, Bonthron DT, Donlon TA, Bruns GA, Latt SA; et al. (1985). "Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization". Science. 228 (4706): 1401–6. PMID 3874428.
  7. 7.0 7.1 Verweij CL, Diergaarde PJ, Hart M, Pannekoek H (1986). "Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit". EMBO J. 5 (8): 1839–47. PMC 1167049. PMID 3019665.
  8. Template:WhoNamedIt

Template:WH Template:WS